Dyadic International starts dosing in Phase 1 clinical trial DYAI-100 booster vaccine candidate

By Proactive Investors / January 27, 2023 / www.youtube.com / Article Link


Dyadic International CEO Mark Emalfarb and Chief Business Officer Joe Hazelton joined Steve Darling from Proactive to share ...

Recent News

Gold stocks outperform equities surge

May 11, 2026 / www.canadianminingreport.com

Global tech once again leading the markets in 2026

May 11, 2026 / www.canadianminingreport.com

Gold stocks decline as equities reach all-time highs

May 04, 2026 / www.canadianminingreport.com

Gold stocks decline on metal pullback

April 27, 2026 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok